The combination of biological information obtained by Next Generation Sequencing (NGS) and BioIT pipelines and databases unleashes the discovery and identification of microorganisms. There is growing interest and, in turn, questions regarding the application of NGS in biologics viral safety programs. Through case studies on cell bank and virus stock characterization, learn how the power of metagenomics is changing the paradigm for biosafety testing.


  • Pascale Beurdeley, PhD, Chief Scientific Officer, PathoQuest
  • Charles Hébert, PhD, Chief Technology and Information Officer, PathoQuest